Back to Search
GEORGE SPENCER-GREEN, MD
MD
Rheumatology Physician
NPI: 1669608378Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
35.038952(OH)
Research & Publications (8)
Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.
PMID 19404957·Arthritis Rheum·2009
2-rct
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
PMID 16385520·Arthritis Rheum·2006
4-observational
ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
PMID 15527547·Inflammopharmacology·2004
8-other
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
PMID 12672185·J Rheumatol·2003
8-other
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
PMID 12115173·Arthritis Rheum·2002
3-trial
Immune function in patients with rheumatoid arthritis treated with etanercept.
PMID 11987981·Clin Immunol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 130 WAVERLY ST, VERTEX CORP
CAMBRIDGE, MA 02139 - Phone
- (617) 444-6398
Quick Facts
- NPI
- 1669608378
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile